Possible adverse effects of SGLT2 inhibitors on bone

Lancet Diabetes Endocrinol. 2015 Jan;3(1):8-10. doi: 10.1016/S2213-8587(14)70227-X. Epub 2014 Dec 16.
No abstract available

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Benzhydryl Compounds / adverse effects
  • Fractures, Bone / chemically induced*
  • Fractures, Bone / epidemiology
  • Fractures, Bone / metabolism
  • Glucosides / adverse effects
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
  • Benzhydryl Compounds
  • Glucosides
  • Hypoglycemic Agents
  • SLC5A2 protein, human
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors